• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成功去除并防止抗HLA抗体重新合成。

Successful removal and prevention of resynthesis of anti-HLA antibody.

作者信息

Taube D H, Welsh K I, Kennedy L A, Thick M G, Bewick M, Cameron J S, Ogg C S, Rudge C J, Williams D G

出版信息

Transplantation. 1984 Mar;37(3):254-5. doi: 10.1097/00007890-198403000-00007.

DOI:10.1097/00007890-198403000-00007
PMID:6367164
Abstract

The successful removal and prevention of the resynthesis of an anti-HLA antibody by plasma exchange and immunosuppression in a patient awaiting renal transplantation is described. Before treatment, the patient's serum contained a high titer (greater than 1/50) anti-HLA antibody that reacted with 94% of our lymphocyte donor panel and produced positive cross matches with the lymphocytes from 40 cadaver kidneys. Following treatment, her anti-HLA titers fell to less than 1/10 and her sera reacted with 43% of our lymphocyte donor panel and produced negative crossmatches with lymphocytes from the first two cadaver kidney donors she was tested against. She was successfully transplanted with the second of these kidneys and is now well eight months later, with good graft function.

摘要

本文描述了一名等待肾移植患者通过血浆置换和免疫抑制成功清除抗 HLA 抗体并防止其重新合成的病例。治疗前,患者血清中含有高滴度(大于 1/50)的抗 HLA 抗体,该抗体与我们 94% 的淋巴细胞供者库发生反应,并与 40 个尸体肾的淋巴细胞产生阳性交叉配型。治疗后,她的抗 HLA 滴度降至小于 1/10,其血清与我们 43% 的淋巴细胞供者库发生反应,并与她接受检测的前两个尸体肾供者的淋巴细胞产生阴性交叉配型。她成功移植了第二个这样的肾脏,八个月后情况良好,移植肾功能正常。

相似文献

1
Successful removal and prevention of resynthesis of anti-HLA antibody.成功去除并防止抗HLA抗体重新合成。
Transplantation. 1984 Mar;37(3):254-5. doi: 10.1097/00007890-198403000-00007.
2
Induction of antiidiotypic antibodies to donor HLA-A2 following blood transfusions in a highly sensitized HLA-A2+ recipient.在一名高度致敏的HLA - A2阳性受者输血后诱导产生针对供体HLA - A2的抗独特型抗体。
Transplantation. 1988 Jun;45(6):1066-71. doi: 10.1097/00007890-198806000-00013.
3
Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab.采用移植前血浆置换和利妥昔单抗治疗,实现交叉配型阳性患者成功进行死亡供体肾移植。
Transplantation. 2009 Mar 15;87(5):668-71. doi: 10.1097/TP.0b013e318198a376.
4
Renal transplantation after removal and prevention of resynthesis of HLA antibodies.去除并预防HLA抗体重新合成后的肾移植。
Lancet. 1984 Apr 14;1(8381):824-8. doi: 10.1016/s0140-6736(84)92273-6.
5
Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.通过抗CD20治疗和移植期血液分离术实现的具有供体特异性HLA抗体患者的活体供肾移植。
Atheroscler Suppl. 2013 Jan;14(1):199-202. doi: 10.1016/j.atherosclerosissup.2012.10.030.
6
Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.供体特异性抗体阳性移植患者肾移植的优异存活情况——静脉注射免疫球蛋白和兔抗胸腺细胞球蛋白的作用
Transplantation. 2009 Jan 27;87(2):227-32. doi: 10.1097/TP.0b013e31818c962b.
7
Panel-reactive antibody levels and renal transplantation rates in sensitized patients after desensitization and human leucocyte antigen amino acid residue matching.脱敏及人类白细胞抗原氨基酸残基匹配后致敏患者的群体反应性抗体水平及肾移植率
J Int Med Res. 2013 Aug;41(4):1333-41. doi: 10.1177/0300060513485896. Epub 2013 Jun 18.
8
Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.肾移植中HLA抗体分析与交叉配型的重新评估
Clin Transpl. 2007:219-26.
9
Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection.人类白细胞抗原(HLA)不相容性、所用免疫抑制方案以及肾移植类型对移植后抗HLA I类抗体产生及排斥反应发生的影响。
Immunopharmacol Immunotoxicol. 2009;31(1):83-7. doi: 10.1080/08923970802365123.
10
Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.使用抗胸腺细胞球蛋白(ATG)单药治疗以及利妥昔单抗、静脉注射免疫球蛋白和血浆置换联合治疗活检证实的急性抗体介导排斥反应:从初步经验中获得的教训
Clin Transpl. 2014:223-30.

引用本文的文献

1
Imlifidase: Is it the Magic Wand in Renal Transplantation?伊姆利菲酶:它是肾移植中的魔杖吗?
Indian J Nephrol. 2024 Jul-Aug;34(4):291-296. doi: 10.25259/ijn_325_23. Epub 2024 Apr 29.
2
HLA Antibody Incompatible Renal Transplantation: Long-term Outcomes Similar to Deceased Donor Transplantation.人类白细胞抗原抗体不相容肾移植:长期结果与尸体供肾移植相似。
Transplant Direct. 2021 Jul 19;7(8):e732. doi: 10.1097/TXD.0000000000001183. eCollection 2021 Aug.
3
IMPORTANCE OF DONOR SELECTION IN RENAL TRANSPLANTATION.肾移植中供体选择的重要性。
Med J Armed Forces India. 1994 Jul;50(3):205-210. doi: 10.1016/S0377-1237(17)31063-8. Epub 2017 Jun 27.
4
Glomerular thrombi in renal allografts associated with cyclosporin treatment.肾移植中与环孢素治疗相关的肾小球血栓形成。
J Clin Pathol. 1985 Mar;38(3):253-8. doi: 10.1136/jcp.38.3.253.